DK0709455T3 - Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an - Google Patents

Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an

Info

Publication number
DK0709455T3
DK0709455T3 DK95307748T DK95307748T DK0709455T3 DK 0709455 T3 DK0709455 T3 DK 0709455T3 DK 95307748 T DK95307748 T DK 95307748T DK 95307748 T DK95307748 T DK 95307748T DK 0709455 T3 DK0709455 T3 DK 0709455T3
Authority
DK
Denmark
Prior art keywords
humanglicentin
antibody
hybridoma
produce
assay method
Prior art date
Application number
DK95307748T
Other languages
English (en)
Inventor
Noboru Yanaihara
Takeya Sato
Kiyoshi Nisshin Flour Fukuchi
Original Assignee
Nisshin Flour Milling Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Flour Milling Co filed Critical Nisshin Flour Milling Co
Application granted granted Critical
Publication of DK0709455T3 publication Critical patent/DK0709455T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/605—Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK95307748T 1994-10-31 1995-10-31 Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an DK0709455T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26656794 1994-10-31
JP7185272A JP2729159B2 (ja) 1994-10-31 1995-07-21 ヒトグリセンチンのモノクローナル抗体、この抗体を産生するハイブリドーマおよびそれを用いるヒトグリセンチンの定量法

Publications (1)

Publication Number Publication Date
DK0709455T3 true DK0709455T3 (da) 1999-02-22

Family

ID=26503007

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95307748T DK0709455T3 (da) 1994-10-31 1995-10-31 Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an

Country Status (7)

Country Link
US (1) US5712105A (da)
EP (1) EP0709455B1 (da)
JP (1) JP2729159B2 (da)
KR (1) KR960014336A (da)
CA (1) CA2161480A1 (da)
DE (1) DE69504620T2 (da)
DK (1) DK0709455T3 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082179A1 (en) * 2001-07-03 2003-05-01 Hutchison James Scott Parathyroid hormone antibodies and related methods
US7361410B2 (en) * 2003-12-29 2008-04-22 Intel Corporation External modification of composite organic inorganic nanoclusters comprising raman active organic compound
US20050191665A1 (en) * 2003-12-29 2005-09-01 Xing Su Composite organic-inorganic nanoclusters
US20080076119A9 (en) * 2003-12-29 2008-03-27 Lei Sun Composite organic inorganic nanoclusters
US20050147963A1 (en) * 2003-12-29 2005-07-07 Intel Corporation Composite organic-inorganic nanoparticles and methods for use thereof
US20070048797A1 (en) * 2004-08-11 2007-03-01 Xing Su Composite organic inorganic nanoclusters as carriers and identifiers of tester molecules
US7776547B2 (en) * 2004-08-26 2010-08-17 Intel Corporation Cellular analysis using Raman surface scanning
US20060147941A1 (en) * 2004-12-30 2006-07-06 Intel Corporation Methods and apparatus for SERS assay of biological analytes
US20070155022A1 (en) * 2005-12-30 2007-07-05 Mineo Yamakawa Degenerate binding detection and protein identification using Raman spectroscopy nanoparticle labels
CA2960763A1 (en) 2014-09-16 2016-03-24 Regeneron Pharmaceuticals, Inc. Anti-glucagon antibodies and uses thereof
EP3506940A1 (en) 2016-08-30 2019-07-10 Regeneron Pharmaceuticals, Inc. Methods of treating severe insulin resistance by interfering with glucagon receptor signaling
WO2018075792A1 (en) 2016-10-20 2018-04-26 Regeneron Pharmaceuticals, Inc. Methods of lowering blood glucose levels
CA3071387A1 (en) 2017-08-22 2019-02-28 Regeneron Pharmaceuticals, Inc. Methods of treating urea cycle disorders by interfering with glucagon receptor signaling

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
JPH0523196A (ja) * 1991-07-17 1993-02-02 Nisshin Flour Milling Co Ltd ヒトグリセンチンのモノクローナル抗体およびそれを用いるヒトグリセンチンの定量法
JPH0680584A (ja) * 1992-07-13 1994-03-22 Nisshin Flour Milling Co Ltd グリセンチンを有効成分とする医薬
JP2961045B2 (ja) * 1993-02-24 1999-10-12 日清製粉株式会社 腸管粘膜増強促進剤
JP2887060B2 (ja) * 1993-06-30 1999-04-26 日清製粉株式会社 グリセンチンの生産方法

Also Published As

Publication number Publication date
KR960014336A (ko) 1996-05-22
CA2161480A1 (en) 1996-05-01
EP0709455B1 (en) 1998-09-09
US5712105A (en) 1998-01-27
JPH08183799A (ja) 1996-07-16
JP2729159B2 (ja) 1998-03-18
DE69504620D1 (de) 1998-10-15
DE69504620T2 (de) 1999-05-06
EP0709455A1 (en) 1996-05-01

Similar Documents

Publication Publication Date Title
PT719859E (pt) Anticorpo monoclonal anti-alfa v-integrina
DK0941344T3 (da) Humaniserede anti-CD11a-antistoffer
DK473887D0 (da) Hybridomacellelinie, monoklonalt antistof, fremgangsmaade til fremstilling af og anvendelse af det monoklonale antistof
DE69920897D1 (de) Monoklonale antikörper mit verringerter immunisierungsfähigkeit
NO962346D0 (no) Humaniserte antistoffer og anvendelser derav
DK0709455T3 (da) Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an
DE69828154D1 (de) Anti-alphavbeta3 humanizierte monoklonale antikörper
DE69738312D1 (de) Hepatitis b monoklonale antikörper
EP1227159A4 (en) MONOCLONAL ANTIBODIES, HYBRIDOMA, IMMUNOASSAY AND DIAGNOSTIC KIT
DK26587D0 (da) Monoklonalt antistof, maalemetode for glucosyleret protein ved anvendelse af det monoklonale antistofog kit omfattende dette
PT840620E (pt) Antagonistas de il-8 para o tratamento de asma
TR199800517A3 (tr) Hümanize anti-hümen fas antikor.
NO972522D0 (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
DK557289A (da) Monoklonalt, fucosylceramiderkendende antistof, dets fremstilling og anvendelse samt hybridoma til fremstillingen
EP0759943A4 (en) MONOCLONAL ANTIBODIES SPECIFIC TO AN ENDOGLYX-1 ANTIGEN OF VASCULAR ENDOTHELIAL CELLS, THE ANTIGEN ITSELF AND USES THEREOF
NO20004251D0 (no) Humaniserte anti-CEA monoklonale antistoffer med høy affinitet
EP0922761A4 (en) MONOCLONAL ANTIBODY, SPECIFIC FOR ANTI-HUMAN FIBRINE MONOMER, METHOD FOR PRODUCING THE SAME, HYBRYDOM CELLS AND AN IMMUNOASSAY METHOD
DK0722952T3 (da) Hypoallergen colostrum-serum-fraktion med høj antistofaktivetet, dens anvendelse og fremgangsmåde til fremstilling af en sådan fraktion
DE69415030D1 (de) Nucleosid derivate, verfahren zu ihrer herstellung und für diese derivate spezifische monoklonale und polyklonale antikörper
EP0654532A4 (en) ANTIMUCOGLYCOPROTEIN MONOCLONAL ANTIBODIES.
BR1100555B1 (pt) anticorpos monoclonais humanizados.
NO20000079L (no) Ancrod spesifikke monoklonale antistoff, antistoff- fragmenter, blandinger, derivater og anvendelse derav
NO985281D0 (no) Monoklonalt antihumant MP52-antistoff
AU2003204560A1 (en) Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
DK321687A (da) Monoklonalt antistof, dets fremstilling og anvendelse samt hybridomaceller til fremstillingen